Skip to main content
Top
Published in: Virology Journal 1/2015

Open Access 01-12-2015 | Research

Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid

Authors: Xiangmin Zhang, Roy Curtiss III

Published in: Virology Journal | Issue 1/2015

Login to get access

Abstract

Background

The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus.

Results

A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 105–106 50 % tissue culture infective dose (TCID50)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin–Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method.

Conclusions

An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust “1 + 2” approach to generate influenza vaccine seed virus.
Literature
1.
go back to reference Noda T, Sagara H, Yen A, Takada A, Kida H, Cheng RH, et al. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature. 2006;439:490–2.PubMedCrossRef Noda T, Sagara H, Yen A, Takada A, Kida H, Cheng RH, et al. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature. 2006;439:490–2.PubMedCrossRef
2.
go back to reference Murti KG, Webster RG, Jones IM. Localization of RNA polymerases on influenza viral ribonucleoproteins by immunogold labeling. Virology. 1988;164:562–6.PubMedCrossRef Murti KG, Webster RG, Jones IM. Localization of RNA polymerases on influenza viral ribonucleoproteins by immunogold labeling. Virology. 1988;164:562–6.PubMedCrossRef
3.
go back to reference Klumpp K, Ruigrok RW, Baudin F. Roles of the influenza virus polymerase and nucleoprotein in forming a functional RNP structure. EMBO J. 1997;16:1248–57.PubMedCentralPubMedCrossRef Klumpp K, Ruigrok RW, Baudin F. Roles of the influenza virus polymerase and nucleoprotein in forming a functional RNP structure. EMBO J. 1997;16:1248–57.PubMedCentralPubMedCrossRef
4.
go back to reference Parvin JD, Palese P, Honda A, Ishihama A, Krystal M. Promoter analysis of influenza virus RNA polymerase. J Virol. 1989;63:5142–52.PubMedCentralPubMed Parvin JD, Palese P, Honda A, Ishihama A, Krystal M. Promoter analysis of influenza virus RNA polymerase. J Virol. 1989;63:5142–52.PubMedCentralPubMed
5.
go back to reference Luytjes W, Krystal M, Enami M, Parvin JD, Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell. 1989;59:1107–13.PubMedCrossRef Luytjes W, Krystal M, Enami M, Parvin JD, Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell. 1989;59:1107–13.PubMedCrossRef
6.
go back to reference Neumann G, Zobel A, Hobom G. RNA polymerase I-mediated expression of influenza viral RNA molecules. Virology. 1994;202:477–9.PubMedCrossRef Neumann G, Zobel A, Hobom G. RNA polymerase I-mediated expression of influenza viral RNA molecules. Virology. 1994;202:477–9.PubMedCrossRef
8.
go back to reference Pleschka S, Jaskunas R, Engelhardt OG, Zurcher T, Palese P, Garcia-Sastre A. A plasmid-based reverse genetics system for influenza A virus. J Virol. 1996;70:4188–92.PubMedCentralPubMed Pleschka S, Jaskunas R, Engelhardt OG, Zurcher T, Palese P, Garcia-Sastre A. A plasmid-based reverse genetics system for influenza A virus. J Virol. 1996;70:4188–92.PubMedCentralPubMed
9.
go back to reference Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A. 1999;96:9345–50.PubMedCentralPubMedCrossRef Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A. 1999;96:9345–50.PubMedCentralPubMedCrossRef
10.
go back to reference Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A. Rescue of influenza A virus from recombinant DNA. J Virol. 1999;73:9679–82.PubMedCentralPubMed Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A. Rescue of influenza A virus from recombinant DNA. J Virol. 1999;73:9679–82.PubMedCentralPubMed
11.
go back to reference Hoffmann E, Webster RG. Unidirectional RNA polymerase I-polymerase II transcription system for the generation of influenza A virus from eight plasmids. J Gen Virol. 2000;81:2843–7.PubMed Hoffmann E, Webster RG. Unidirectional RNA polymerase I-polymerase II transcription system for the generation of influenza A virus from eight plasmids. J Gen Virol. 2000;81:2843–7.PubMed
12.
go back to reference Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A. 2000;97:6108–13.PubMedCentralPubMedCrossRef Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A. 2000;97:6108–13.PubMedCentralPubMedCrossRef
13.
go back to reference Heix J, Grummt I. Species specificity of transcription by RNA polymerase I. Curr Opin Genet Dev. 1995;5:652–6.PubMedCrossRef Heix J, Grummt I. Species specificity of transcription by RNA polymerase I. Curr Opin Genet Dev. 1995;5:652–6.PubMedCrossRef
14.
go back to reference Murakami S, Horimoto T, Yamada S, Kakugawa S, Goto H, Kawaoka Y. Establishment of canine RNA polymerase I-driven reverse genetics for influenza A virus: its application for H5N1 vaccine production. J Virol. 2008;82:1605–9.PubMedCentralPubMedCrossRef Murakami S, Horimoto T, Yamada S, Kakugawa S, Goto H, Kawaoka Y. Establishment of canine RNA polymerase I-driven reverse genetics for influenza A virus: its application for H5N1 vaccine production. J Virol. 2008;82:1605–9.PubMedCentralPubMedCrossRef
15.
go back to reference Wang Z, Duke GM. Cloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells. Virol J. 2007;4:102.PubMedCentralPubMedCrossRef Wang Z, Duke GM. Cloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells. Virol J. 2007;4:102.PubMedCentralPubMedCrossRef
16.
go back to reference Massin P, Rodrigues P, Marasescu M, van der Werf S, Naffakh N. Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells. J Virol. 2005;79:13811–6.PubMedCentralPubMedCrossRef Massin P, Rodrigues P, Marasescu M, van der Werf S, Naffakh N. Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells. J Virol. 2005;79:13811–6.PubMedCentralPubMedCrossRef
17.
go back to reference de Wit E, Spronken MI, Vervaet G, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. A reverse-genetics system for Influenza A virus using T7 RNA polymerase. J Gen Virol. 2007;88:1281–7.PubMedCrossRef de Wit E, Spronken MI, Vervaet G, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. A reverse-genetics system for Influenza A virus using T7 RNA polymerase. J Gen Virol. 2007;88:1281–7.PubMedCrossRef
18.
go back to reference Neumann G, Fujii K, Kino Y, Kawaoka Y. An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A. 2005;102:16825–9.PubMedCentralPubMedCrossRef Neumann G, Fujii K, Kino Y, Kawaoka Y. An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A. 2005;102:16825–9.PubMedCentralPubMedCrossRef
19.
go back to reference Zhang X, Kong W, Ashraf S, Curtiss III R. A one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine. J Virol. 2009;83:9296–303.PubMedCentralPubMedCrossRef Zhang X, Kong W, Ashraf S, Curtiss III R. A one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine. J Virol. 2009;83:9296–303.PubMedCentralPubMedCrossRef
20.
go back to reference Chen H, Angel M, Li W, Finch C, Gonzalez AS, Sutton T, et al. All-in-one bacmids: an efficient reverse genetics strategy for influenza A virus vaccines. J Virol. 2014;88:10013–25.PubMedCentralPubMedCrossRef Chen H, Angel M, Li W, Finch C, Gonzalez AS, Sutton T, et al. All-in-one bacmids: an efficient reverse genetics strategy for influenza A virus vaccines. J Virol. 2014;88:10013–25.PubMedCentralPubMedCrossRef
21.
22.
go back to reference Maassab HF, Bryant ML. The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev Med Virol. 1999;9:237–44.PubMedCrossRef Maassab HF, Bryant ML. The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev Med Virol. 1999;9:237–44.PubMedCrossRef
23.
go back to reference Nicolson C, Major D, Wood JM, Robertson JS. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine. 2005;23:2943–52.PubMedCrossRef Nicolson C, Major D, Wood JM, Robertson JS. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine. 2005;23:2943–52.PubMedCrossRef
24.
go back to reference Chen Z, Aspelund A, Kemble G, Jin H. Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist). Virology. 2006;345:416–23.PubMedCrossRef Chen Z, Aspelund A, Kemble G, Jin H. Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist). Virology. 2006;345:416–23.PubMedCrossRef
25.
26.
go back to reference Jin H, Lu B, Zhou H, Ma C, Zhao J, Yang CF, et al. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology. 2003;306:18–24.PubMedCrossRef Jin H, Lu B, Zhou H, Ma C, Zhao J, Yang CF, et al. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology. 2003;306:18–24.PubMedCrossRef
27.
go back to reference Minor PD, Engelhardt OG, Wood JM, Robertson JS, Blayer S, Colegate T, et al. Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK. Vaccine. 2009;27:2907–13.PubMedCrossRef Minor PD, Engelhardt OG, Wood JM, Robertson JS, Blayer S, Colegate T, et al. Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK. Vaccine. 2009;27:2907–13.PubMedCrossRef
28.
go back to reference Zhang X, Kong W, Wanda SY, Xin W, Alamuri P, Curtiss III R. Generation of influenza virus from avian cells infected by Salmonella carrying the viral genome. PLoS One. 2015;10:e0119041.PubMedCentralPubMedCrossRef Zhang X, Kong W, Wanda SY, Xin W, Alamuri P, Curtiss III R. Generation of influenza virus from avian cells infected by Salmonella carrying the viral genome. PLoS One. 2015;10:e0119041.PubMedCentralPubMedCrossRef
29.
go back to reference Kallel H, Diouani MF, Loukil H, Trabelsi K, Snoussi MA, Majoul S, et al. Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine. Vaccine. 2006;24:4856–62.PubMedCrossRef Kallel H, Diouani MF, Loukil H, Trabelsi K, Snoussi MA, Majoul S, et al. Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine. Vaccine. 2006;24:4856–62.PubMedCrossRef
30.
go back to reference Reculard P. Cell-culture vaccines for veterinary use. In: Meslin FX, Kaplan MM, Koprowski H, editors. Laboratory techniques in rabies. 4th ed. Geneva, Switzerland: World Health Organization; 1996. p. 314–23. Reculard P. Cell-culture vaccines for veterinary use. In: Meslin FX, Kaplan MM, Koprowski H, editors. Laboratory techniques in rabies. 4th ed. Geneva, Switzerland: World Health Organization; 1996. p. 314–23.
31.
go back to reference Kim JY, Kim YG, Lee GM. CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Appl Microbiol Biotechnol. 2012;93:917–30.PubMedCrossRef Kim JY, Kim YG, Lee GM. CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Appl Microbiol Biotechnol. 2012;93:917–30.PubMedCrossRef
32.
go back to reference Govorkova EA, Matrosovich MN, Tuzikov AB, Bovin NV, Gerdil C, Fanget B, et al. Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells. Virology. 1999;262:31–8.PubMedCrossRef Govorkova EA, Matrosovich MN, Tuzikov AB, Bovin NV, Gerdil C, Fanget B, et al. Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells. Virology. 1999;262:31–8.PubMedCrossRef
33.
go back to reference Merten OW, Manuguerra JC, Hannoun C, van der Werf S. Production of influenza virus in serum-free mammalian cell cultures. Dev Biol Stand. 1999;98:23–37.PubMed Merten OW, Manuguerra JC, Hannoun C, van der Werf S. Production of influenza virus in serum-free mammalian cell cultures. Dev Biol Stand. 1999;98:23–37.PubMed
35.
go back to reference Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis. 2006;194 Suppl 2:S111–8.PubMedCrossRef Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis. 2006;194 Suppl 2:S111–8.PubMedCrossRef
36.
go back to reference Kreiss P, Cameron B, Rangara R, Mailhe P, Aguerre-Charriol O, Airiau M, et al. Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res. 1999;27:3792–8.PubMedCentralPubMedCrossRef Kreiss P, Cameron B, Rangara R, Mailhe P, Aguerre-Charriol O, Airiau M, et al. Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res. 1999;27:3792–8.PubMedCentralPubMedCrossRef
37.
go back to reference Sieben C, Kappel C, Zhu R, Wozniak A, Rankl C, Hinterdorfer P, et al. Influenza virus binds its host cell using multiple dynamic interactions. Proc Natl Acad Sci U S A. 2012;109:13626–31.PubMedCentralPubMedCrossRef Sieben C, Kappel C, Zhu R, Wozniak A, Rankl C, Hinterdorfer P, et al. Influenza virus binds its host cell using multiple dynamic interactions. Proc Natl Acad Sci U S A. 2012;109:13626–31.PubMedCentralPubMedCrossRef
38.
go back to reference Monaco L, Marc A, Eon-Duval A, Acerbis G, Distefano G, Lamotte D, et al. Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ. Cytotechnology. 1996;22:197–203.PubMedCrossRef Monaco L, Marc A, Eon-Duval A, Acerbis G, Distefano G, Lamotte D, et al. Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ. Cytotechnology. 1996;22:197–203.PubMedCrossRef
40.
41.
go back to reference Londrigan SL, Turville SG, Tate MD, Deng YM, Brooks AG, Reading PC. N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN. J Virol. 2011;85:2990–3000.PubMedCentralPubMedCrossRef Londrigan SL, Turville SG, Tate MD, Deng YM, Brooks AG, Reading PC. N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN. J Virol. 2011;85:2990–3000.PubMedCentralPubMedCrossRef
42.
go back to reference Ng WC, Liong S, Tate MD, Irimura T, Denda-Nagai K, Brooks AG, et al. The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus. J Virol. 2014;88:1659–72.PubMedCentralPubMedCrossRef Ng WC, Liong S, Tate MD, Irimura T, Denda-Nagai K, Brooks AG, et al. The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus. J Virol. 2014;88:1659–72.PubMedCentralPubMedCrossRef
43.
go back to reference Lin N, Mascarenhas J, Sealover NR, George HJ, Brooks J, Kayser KJ, et al. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression. Biotechnol Prog. 2015;31:334–46.PubMedCrossRef Lin N, Mascarenhas J, Sealover NR, George HJ, Brooks J, Kayser KJ, et al. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression. Biotechnol Prog. 2015;31:334–46.PubMedCrossRef
44.
go back to reference Song MS, Baek YH, Pascua PN, Kwon HI, Park SJ, Kim EH, et al. Establishment of Vero cell RNA polymerase I-driven reverse genetics for Influenza A virus and its application for pandemic (H1N1) 2009 influenza virus vaccine production. J Gen Virol. 2013;94:1230–5.PubMedCrossRef Song MS, Baek YH, Pascua PN, Kwon HI, Park SJ, Kim EH, et al. Establishment of Vero cell RNA polymerase I-driven reverse genetics for Influenza A virus and its application for pandemic (H1N1) 2009 influenza virus vaccine production. J Gen Virol. 2013;94:1230–5.PubMedCrossRef
45.
go back to reference Suphaphiphat P, Keiner B, Trusheim H, Crotta S, Tuccino AB, Zhang P, et al. Human RNA polymerase I-driven reverse genetics for influenza a virus in canine cells. J Virol. 2010;84:3721–5.PubMedCentralPubMedCrossRef Suphaphiphat P, Keiner B, Trusheim H, Crotta S, Tuccino AB, Zhang P, et al. Human RNA polymerase I-driven reverse genetics for influenza a virus in canine cells. J Virol. 2010;84:3721–5.PubMedCentralPubMedCrossRef
46.
go back to reference Laban A, Cohen A. Interplasmidic and intraplasmidic recombination in Escherichia coli K-12. Mol Gen Genet. 1981;184:200–7.PubMed Laban A, Cohen A. Interplasmidic and intraplasmidic recombination in Escherichia coli K-12. Mol Gen Genet. 1981;184:200–7.PubMed
47.
go back to reference Matfield M, Badawi R, Brammar WJ. Rec-dependent and Rec-independent recombination of plasmid-borne duplications in Escherichia coli K12. Mol Gen Genet. 1985;199:518–23.PubMedCrossRef Matfield M, Badawi R, Brammar WJ. Rec-dependent and Rec-independent recombination of plasmid-borne duplications in Escherichia coli K12. Mol Gen Genet. 1985;199:518–23.PubMedCrossRef
48.
go back to reference Hartman PS. Transillumination can profoundly reduce transformation frequencies. Biotechniques. 1991;11:747–8.PubMed Hartman PS. Transillumination can profoundly reduce transformation frequencies. Biotechniques. 1991;11:747–8.PubMed
49.
go back to reference Rand KN. Crystal violet can be used to visualize DNA bands during gel electrophoresis and to improve cloning efficiency. Tech Tips Online. 1996;1:23–4.CrossRef Rand KN. Crystal violet can be used to visualize DNA bands during gel electrophoresis and to improve cloning efficiency. Tech Tips Online. 1996;1:23–4.CrossRef
50.
go back to reference Zhang X, Wanda SY, Brenneman K, Kong W, Roland K, Curtiss III R. Improving Salmonella vector with rec mutation to stabilize the DNA cargoes. BMC Microbiol. 2011;11:31.PubMedCentralPubMedCrossRef Zhang X, Wanda SY, Brenneman K, Kong W, Roland K, Curtiss III R. Improving Salmonella vector with rec mutation to stabilize the DNA cargoes. BMC Microbiol. 2011;11:31.PubMedCentralPubMedCrossRef
Metadata
Title
Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid
Authors
Xiangmin Zhang
Roy Curtiss III
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2015
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-015-0321-5

Other articles of this Issue 1/2015

Virology Journal 1/2015 Go to the issue